- JAK inhibitor that targets JAK1
- Indications include rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ankylosing spondylitis, Crohn disease, and ulcerative colitis
- Adverse effects include: upper respiratory tract infection, nausea, hepatotoxicity
- Reports of lymphopenia, neutropenia, and anemia
